Ian Haydock
Editor In Chief, Pharma, APAC
Japan
35+ years of experience
Datamonitor Healthcare
By Ian Haydock 15 Jun 2022
Listen to this insightful presentation of the unique challenges and opportunities faced by Japan Pharma, hosted by the expert analysts from Pharma Intelligence.
Scrip
By Ian Haydock 01 Dec 2021
Join the Asia Pacific content team for a wide-ranging overview and analysis of recent developments across China, India, South Korea and Japan in the policy, regulatory, commercial and vaccines spaces over the past few months.
Scrip
By Ian Haydock 28 Nov 2021
In this week's podcast edition of Five Must-Know Things: the prospects and plans for J&J’s pharma and oncology business; China looks more inward under new policies; an important US approval for Takeda; and Moderna’s co-founder shares tips on innovation.
Scrip
By Ian Haydock 26 Oct 2021
In this week's podcast edition of Five Must-Know Things: a slow start for Biogen’s Aduhelm; J&J looks to transition COVID vaccine to commercial sales; 2seventy bio spins out from bluebird bio; UCB faces bimekizumab delays; and progress and setbacks in gene therapy.
Scrip
By Ian Haydock 26 Sep 2021
In this week's podcast edition of Five Must-Know Things: an interview with the president of Novartis Pharma; Biogen highlights its pipeline; standout comparative data for Enhertu in breast cancer; Sanofi/Regeneron nip at Keytruda’s heels in first-line lung cancer; and a look at the market prospects for wet AMD.
Scrip
By Ian Haydock 06 Sep 2021
In this week's podcast edition of Five Must-Know Things: new US warnings for JAK inhibitors; strong new heart failure results for Jardiance; good head-to-head results for Pfizer in atopic dermatitis; US payers and drug exclusion lists; and a look ahead at key expected hematology launches.
Scrip
By Ian Haydock 16 Aug 2021
In this week's podcast edition of Five Must-Know Things: a history of Alzheimer’s drug development; BioNTech looks beyond COVID-19 vaccines; gene therapy setbacks for bluebird; new promise for Roche’s Polivy in B-cell lymphoma; and rising US momentum for US drug price negotiations.
Scrip
By Ian Haydock 25 Jul 2021
In this week's podcast edition of Five Must-Know Things: J&J’s outlook for coronavirus vaccines; Cosentyx comes in strong for Novartis; Biogen’s views on Aduhelm pricing; competition in the “dustat” sector; and dealing with endemic COVID-19.
Scrip
By Ian Haydock 05 Jul 2021
In this week's podcast edition of Five Must-Know Things: vaccine efficacy and the Delta and Delta Plus variants; breakthroughs in CRISPR gene editing and microbiome therapies; and the pandemic’s possible effect on regulatory pathways.
Scrip
By Ian Haydock 27 Jun 2021
In this week's podcast edition of Five Must-Know Things: a look at pharma CEO pay; Pfizer’s CEO gives the inside track on COVID vaccine development; GSK elaborates on its restructuring and strategic plans; and Kite talks about its cell therapy plans under Gilead.
Scrip
By Ian Haydock 20 Jun 2021
In this week's podcast edition of Scrip's Five Must-Know Things: new developments in the TIGIT field; doctor frustration over Aduhelm guidance; are pediatric COVID vaccines necessary: the battle of the SERDs; and one Indian firm’s plans for lung disease leadership.
Scrip
By Ian Haydock 15 Mar 2021
In this week's podcast version of Five Must-Know Things, hear about Roche's deal-making in a pandemic, coronavirus vaccine disinformation, Amgen’s Five Prime acquisition, a Novartis clinical trial failure, and new data for a Merck antiviral for the coronavirus.
Scrip
By Ian Haydock 29 Nov 2020
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things
Scrip
By Ian Haydock 27 Nov 2020
As part of broader efforts to pursue novel approaches to common neurological disorders, Eisai uses iPSC-derived cells to help identify potential new drug therapies for Parkinson's.
Topic Parkinson's Disease
Scrip
By Ian Haydock 17 Nov 2020
Take a brief audio tour around the main biopharma industry events of the past week, as brought to you by Scrip's global team, in this podcast version of Five Must-Know Things.
Topic Coronavirus M A
Scrip
25 May 2022
Scrip
08 Mar 2022
Scrip
27 Jan 2022
Scrip
27 Jan 2022
Scrip
20 Jan 2022
Scrip
21 Dec 2021
Pink Sheet
30 Nov 2021
Scrip
15 Nov 2021
Scrip
07 Oct 2021
Pink Sheet
04 Oct 2021
Scrip
30 Sep 2021
Scrip
18 Aug 2021
Pink Sheet
25 Jun 2021
Scrip
08 Jun 2021
Scrip
03 Jun 2021